Revolution Medicines SG&A Expenses 2018-2025 | RVMD

Revolution Medicines sg&a expenses for the twelve months ending March 31, 2025 were $0.109B, a 28.44% increase year-over-year.

  • Revolution Medicines annual sg&a expenses for 2024 were $0.097B, a 28.67% increase from 2023.
  • Revolution Medicines annual sg&a expenses for 2023 were $0.076B, a 86.32% increase from 2022.
  • Revolution Medicines annual sg&a expenses for 2022 were $0.041B, a 33.29% increase from 2021.

Revolution Medicines SG&A Expenses 2018-2025 | RVMD

  • Revolution Medicines annual sg&a expenses for 2024 were $0.097B, a 28.67% increase from 2023.
  • Revolution Medicines annual sg&a expenses for 2023 were $0.076B, a 86.32% increase from 2022.
  • Revolution Medicines annual sg&a expenses for 2022 were $0.041B, a 33.29% increase from 2021.